Nuclear ERK1/2 Drives a Futile NAD+ Cycle that Locks Cells into Senescence
Hypothesis: Nuclear ERK1/2 Orchestrates a NAD+‑Dependent Senescence Lock
Core idea Prolonged nuclear retention of ERK1/2 in aged or stressed cells does not merely report senescence; it actively rewires NAD+ metabolism to reinforce the arrest. Nuclear ERK phosphorylates and stabilizes the NAD+ salvage enzyme NAMPT and the chromatin adaptor HMGA, boosting NAD+ synthesis while simultaneously recruiting PARP1 to DNA damage sites, increasing NAD+ consumption. The resulting futile cycle raises local NAD+ turnover, depleting the pool available for sirtuin‑driven proliferative programs and shifting NAD+ usage toward SASP‑supporting pathways. In this view, NAD+ decline is a downstream consequence of ERK‑driven metabolic reprogramming, not an upstream cause.
Testable predictions
- Inhibiting ERK nuclear export (e.g., with leptomycin B or PEA‑15 overexpression) will increase NAMPT and HMGA protein levels and PARP1 chromatin binding, leading to measurable NAD+ flux shifts (↑ synthesis, ↑ consumption) within 6 h.
- Genetic knockdown of nuclear ERK2 will blunt the NAD+ upregulation normally seen in senescence‑induced cells and reduce SASP secretion despite persistent DNA damage.
- Supplementing NAD+ precursors (NR or NMN) will exacerbate SASP intensity only when ERK remains nuclear; combined ERK export enhancement will normalize SASP levels.
- Live‑cell FRET‑based NAD+ sensors will show microdomains of elevated NAD+ turnover at chromatin foci co‑localizing with phospho‑ERK1/2 in senescent fibroblasts, but not in proliferating controls.
Falsifiable outcomes If nuclear ERK manipulation fails to alter NAMPT/HMGA levels, PARP1 recruitment, or NAD+ flux, or if NAD+ supplementation does not modify SASP in an ERK‑dependent manner, the hypothesis would be refuted. Conversely, confirming any two of the predictions would strongly support the model.
Novel mechanistic link ERK‑dependent phosphorylation of NAMPT at serine‑xx (predicted from consensus motifs) enhances its affinity for PRPP, accelerating NAD+ salvage. Simultaneously, ERK‑mediated HMGA phosphorylation reduces its acetylation, increasing chromatin binding and scaffolding PARP1 to nucleosomes. This dual action creates a spatially confined NAD+ cycle that fuels PARP‑driven NAD+ consumption while the salvage pathway attempts to replenish it, establishing a futile loop that locks the cell into a senescent metabolic state.
References 1 – ERK1/2 nuclear‑cytoplasmic shuttling in senescence. 2 – NAMPT/HMGA upregulation fuels SASP. 3 – NAD+ as an active epigenetic‑metabolic adaptation. 4 – ERK‑driven PARP1 activation consumes NAD+ during DNA damage response.